SCHEMBL29480723

SCHEMBL29480723

CS(=O)(=O)NCCC(c1ccc(-n2cc(-c3ccnc(N)c3[N+](=O)[O-])cn2)nc1)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29480751 0.91 — —
SCHEMBL22735968 0.91 — —
SCHEMBL29480676 0.89 GCG (0.32) —
SCHEMBL29480678 0.88 — —
SCHEMBL29480669 0.86 GRM4 (0.31) —
SCHEMBL22735946 0.86 GRM4 (0.31) —
SCHEMBL29480659 0.86 GRM4 (0.31) —
SCHEMBL22716933 0.82 CSNK2A2 (0.33) —
SCHEMBL29480665 0.82 RIPK2 (0.33) —
SCHEMBL29480660 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976612-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD (IN) 2022-04-06 — — EP disclosed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 — — CN disclosed
Send feedback